Cargando…
d-glutamate and Gut Microbiota in Alzheimer’s Disease
Background: An increasing number of studies have shown that the brain–gut–microbiota axis may significantly contribute to Alzheimer’s disease (AD) pathogenesis. Moreover, impaired memory and learning involve the dysfunction neurotransmission of glutamate, the agonist of the N-methyl-d-aspartate rece...
Autores principales: | Chang, Chun-Hung, Lin, Chieh-Hsin, Lane, Hsien-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215955/ https://www.ncbi.nlm.nih.gov/pubmed/32290475 http://dx.doi.org/10.3390/ijms21082676 |
Ejemplares similares
-
Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer’s Disease
por: Chang, Chun-Hung, et al.
Publicado: (2021) -
Brain Stimulation in Alzheimer's Disease
por: Chang, Chun-Hung, et al.
Publicado: (2018) -
Cystine/Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment
por: Hung, Chung-Chieh, et al.
Publicado: (2021) -
Diagnosing Alzheimer’s Disease Specifically and Sensitively With pLG72 and Cystine/Glutamate Antiporter SLC7A11 AS Blood Biomarkers
por: Lane, Hsien-Yuan, et al.
Publicado: (2022) -
d-Amino Acids and pLG72 in Alzheimer’s Disease and Schizophrenia
por: Cheng, Yu-Jung, et al.
Publicado: (2021)